After Hours
$
217.33
Change
+1.35 +0.63%
Volume
Volume 64,473
Jul 6, 2022, 7:52 p.m.
Quotes are delayed by 20 min
Previous close
$ 212.58
$ 215.98
Change
+3.40 +1.60%
Day low
Day high
$211.17
$216.80

52 week low
52 week high
$187.16
$372.12

Market cap
$31.13B
Average volume
1.16M
P/E ratio
22.13
Rev. per Employee
$1.06M
EPS
9.76
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on BIIB
-
Alzheimer's Drug Is Up for Approval. Outlook for Biogen, Eisai Is Uncertain.
- Josh Nathan-Kazis
-
Biogen stops clinical trial tracking Aduhelm
- Jaimy Lee
-
Seven reasons the beleaguered biotech sector is now a ‘buy’
- Michael Brush
-
Roche's Failed Alzheimer's Trial Could Have Implications for Lilly, Biogen
- Josh Nathan-Kazis
-
Sage Stock Rises on Postpartum Depression Drug Data
- Josh Nathan-Kazis
-
Who Will Lead Biogen? Here Are Some Likely Picks.
- Josh Nathan-Kazis
-
How to Avoid the Biotech Bear Market: Get Some Products Approved
- Josh Nathan-Kazis
-
Biogen Partner Eisai Files for Accelerated Approval of Alzheimer's Drug
- Josh Nathan-Kazis
-
Biotech Stocks Are Having a Terrible Year. These 10 Are Still Winning.
- Josh Nathan-Kazis
-
Stocks Inch Higher to End in the Green. Inflation Is Still a Dark Cloud.
- Jacob Sonenshine
-
Biogen Searches for New CEO in Wake of Struggles With Alzheimer's Drug
- Sabrina Escobar
-
Biogen CEO Michel Vounatsos to step down
- Jaimy Lee
-
Biogen CEO Michel Vounatsos is leaving the company as soon as successor has been found
- Ciara Linnane
- Loading more headlines...
Analyst Ratings
-
Why Barclays Upgraded Merck to ‘Overweight’ on April 5
- MarketRealist.com
-
Barclays Downgrades Pfizer Stock and Cuts Price Target
- MarketRealist.com
-
Benzinga's Top Upgrades, Downgrades For April 5, 2018
- Benzinga.com
Other News on BIIB
-
Is This Biotech Stock a Bad News Buy?
- Motley Fool
-
Wide-Moat Stocks On Sale - The July 2022 Heat Map
- Seeking Alpha
-
- The Editorial Board
-
The Alzheimer’s Cure Conundrum
- Andy Kessler
-
5 Stocks in S&P 500 ETF That Gained Last Week
- Zacks.com
-
Organon Vs. Viatris: Who Is The Clear Winner?
- Seeking Alpha
-
Wells Fargo names 50 stocks to short (or at least avoid)
- Seeking Alpha
-
Wall Street Breakfast: What Moved Markets
- Seeking Alpha
- Loading more headlines...
Press Releases on BIIB
-
Biogen Inc. Common Stock (BIIB) Trading Report
- Stock Traders Daily
-
When the Price of Biogen Inc. Common Stock BIIB Talks, People Listen
- Stock Traders Daily
-
Learn to Evaluate Biogen Inc. Common Stock (BIIB) using the Charts
- Stock Traders Daily
-
Biogen Inc. Common Stock (BIIB) Trading Report
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com